CFS
MRNA icon

Capital Financial Services’s Moderna MRNA Stock Holding History

Capital Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.09M Sell
11,639
-830
-7% -$136K 2.88% 8
2022
Q3 		$1.47M Buy
12,469
+85
+0.7% +$12.9K 2.18% 11
2022
Q2 		$1.77M Buy
12,384
+230
+2% +$32.9K 2.49% 10
2022
Q1 		$2.09M Buy
12,154
+100
+0.8% +$16.8K 2.46% 9
2021
Q4 		$3.06M Buy
12,054
+9,949
+473% +$2.91M 3.34% 7
2021
Q3 		$810K Buy
+2,105
New +$776K 0.99% 37

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Financial Services's MRNA Position: Q4 2022 in Review

Capital Financial Services reduced its Moderna (MRNA) stake by 6.7% in Q4 2022, selling an estimated $136K and leaving 11,639 shares worth $2.09M. The position accounts for 2.88% of the portfolio, ranked #8.

Capital Financial Services first reported a position in MRNA in Q3 2021 and has held it in 6 quarters since. The position peaked at $3.06M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Capital Financial Services held 11,639 shares of Moderna worth $2.09M as of Q4 2022.
  • Capital Financial Services sold 830 Moderna shares in Q4 2022, an estimated $136K.
  • Moderna made up 2.88% of Capital Financial Services's portfolio in Q4 2022, its #8 holding.
  • Capital Financial Services first reported a position in Moderna in Q3 2021 and has held it in 6 quarters since.
  • Capital Financial Services's Moderna position peaked at $3.06M in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.